Search results
Showing results for
Thousands of genes are involved in the regulation of our day-to-day metabolism and relatively little is understood about their function. One key protein, an ABC Transporter called ABCC5, has recently been predicted to be a susceptibility gene for Type 2 diabetes. In a new study selected as Editor's Choice in Obesity, Associate Professor Heidi de Wet has confirmed ABCC5's role in energy metabolism and identified the mechanism behind its metabolic impact for the first time.
Oxford Parkinson’s Disease Centre collaborators announced as Group Leaders for new Parkinson’s Research Centre
28 May 2026
Congratulations to Oxford Parkinson’s Disease Centre (OPDC) investigators, Professor Peter Magill, Professor of Neurobiology, Brain Network Dynamics Unit, Nuffield Department of Clinical Neurosciences, and Professor Laura Parkkinen, Professor of Translational Neuropathology, Nuffield Department of Clinical Neurosciences on their appointment to Group Leader roles in the new Parkinson’s Research Centre (PRC) - a £10m partnership between Parkinson’s UK and the UK Dementia Research Institute (UK DRI) dedicated to better understand the causes of Parkinson’s and to accelerate new and improved treatments for the condition.
Oxford researchers join global network unravelling the complexity of Parkinson’s disease
26 May 2026
Professor Andrew Sharott (Team leader) and Professor Laura Parkkinen (Co-Investigator) from Nuffield Department of Clinical Neurosciences (NDCN) have been selected for multi-year grants to join the Collaborative Research Network (CRN) an international, multidisciplinary, multi-institutional network working to address high-priority research questions about Parkinson's disease. Read full story: https://www.medsci.ox.ac.uk/news/oxford-researchers-join-global-network-unravelling-the-complexity-of-parkinsons-disease